Aquilo Capital, L.P.'s Form 4 filing
Spero Therapeutics, Inc. (SPRO) · filed Mar 31, 2022
- Accession no.
- 0001591986-22-000014
- Filed
- Mar 31, 2022, 3:51 PM ET
- Trade date
- Mar 30, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $439.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aquilo Capital, L.P.CIK 0001491371 | 10% Owner |
| Aquilo Capital Management, LLCCIK 0001591986 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2022 | Common Stock, $0.001 par value | PPurchaseAcquired | +33,115 | $8.79 | +$291,027.87 | 5,264,619 | Indirect | |
| Mar 30, 2022 | Common Stock, $0.001 par value | PPurchaseAcquired | +16,885 | $8.79 | +$148,392.13 | 5,281,504 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.